Belviq Cancer
If you have taken Belviq to lose weight, you might be at an increased risk of developing cancer. Belviq cancer lawsuits compensate people with specific types of cancer after taking Belviq. Contact us for a free legal consultation.
Belviq Linked to Cancer
Lorcaserin, or Belviq—its brand name, is a popular medication that is under fire. This prescription medication is linked to many types of cancer. Here is all the information you need to know about Belviq:
What is Belviq?
Belviq, also known as Lorcaserin, is a prescription weight loss medication. Doctors prescribe Belviq to help certain people lose weight. It is taken once or twice per day and creates a feeling of fullness; thus suppressing the appetite.
FDA Rejected Belviq
Arena Pharmaceuticals created Belviq to control appetite. This medication has a troubled past and was initially rejected by the FDA in 2010. In 2012, the FDA finally approved Belviq with restrictions and patient monitoring. In 2017, Eisai took over all rights to Lorcaserin (Belviq) production.
Weight Loss Miracle
This medicine is prescribed for people with weight-related medical conditions i.e. diabetes II or cardiovascular disease. Belviq was billed as a weight-loss miracle pill. People with trouble losing weight were promised an easier way with this prescription.
5-Year Study
Over the course of 5 years, over 12,000 people were monitored with both a placebo and the drug. The results proved the risks outweigh the benefits of the product.
Risks of Using Belviq
8% of Belviq users develop cancer with long-term use. The kinds of cancer linked to this drug are:
- colorectal cancer
- pancreatic cancer
- lung cancer
Belviq Recall
Belviq is on recall due to its link to certain cancers. In 2020, scientific evidence and long-term studies of patients using Belviq showed an increased risk for cancer. The FDA asked Eisai to voluntarily recall their product.
Belviq Cancer Lawsuits
People taking prescription Belviq were not told of the higher possibility of developing cancer. The manufacturer was aware of the increased cancer risk, but it did not warn the people taking Belviq.
Product Liability
In this situation, Arena Pharmaceuticals, and subsequently Eisai, knew there was a problem with their pills. In 2009, the company’s own data showed an increase of tumors in rats exposed to Belviq. Yet, the company did not warn doctors and patients of the cancer risk.
Legal Obligation
The manufacturer has a legal obligation to warn of the risks of cancer with their products. When known side-effects aren’t listed, patients can’t make an informed decision.
Belviq Cancer Lawsuits
Because Eilais knew of the increased risk of cancer, it was the company’s duty to disclose it to doctors and patients. The company did not warn people of this danger. As a result, patients that took Belviq and develop cancer are eligible to sue for damages.
Belviq Cancer Attorney
If you were tricked into thinking Belviq was safe, you’re not alone. Your next step is to contact a personal injury attorney. If you were prescribed Belviq and now have colorectal, pancreatic, or lung cancer, call us today.
Free Belviq Cancer Consultation
At Haggerty & Silverman, you never have to pay us any upfront fees. Consultations are always free and confidential. When you call us, you’ll talk to a real lawyer about your situation and we’ll explain your options. Contact us today for a free consultation.